South Australian scientists have made a significant advance in overcoming drug resistance among patients with acute myeloid leukaemia, a rare blood cancer that kills most sufferers within a few years.
Researchers from the University of South Australia and SA Pathology's Centre for Cancer Biology have discovered a way to suppress a specific protein that promotes resistance to drugs commonly used to treat AML patients.
